ATSN-201 was given regenerative medicine advanced therapy designation to treat X-linked retinoschisis, for which there ...

The FDA granted regenerative medicine advanced therapy designation to ATSN-201, a gene therapy candidate for the treatment of ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about what a retinal detachment is, including causes and symptoms.

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about Retinal Detachment Repair and the various types of surgery.

When it comes to floaters and flashes, the NHS explains seeing "dots and lines (floaters) or flashes of light" in your vision ...